Publication | Closed Access

The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response

InfertilityHormonal ContraceptiveDevelopmental BiologyFertilityPoor Ovarian ResponseHuman GrowthOvulation InductionReproductive HealthGynecologyReproductive HormoneReproductive BiologyPublic HealthEndocrinologyMedicineMenstrual CycleOvarian HormoneWomen's HealthOvarian Cancer